These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9639037)
1. Expression of cytoskeletal proteins differentiates between progressors and non-progressors in treated idiopathic membranous nephropathy. Tamimi NA; Stevens PE; O'Donnell PL; Strange PG; Muchaneta-Kubara EC; El Nahas AM Exp Nephrol; 1998; 6(3):217-25. PubMed ID: 9639037 [TBL] [Abstract][Full Text] [Related]
2. Myofibroblasts and the progression of diabetic nephropathy. Essawy M; Soylemezoglu O; Muchaneta-Kubara EC; Shortland J; Brown CB; el Nahas AM Nephrol Dial Transplant; 1997 Jan; 12(1):43-50. PubMed ID: 9027772 [TBL] [Abstract][Full Text] [Related]
3. Interstitial myofibroblasts: predictors of progression in membranous nephropathy. Roberts IS; Burrows C; Shanks JH; Venning M; McWilliam LJ J Clin Pathol; 1997 Feb; 50(2):123-7. PubMed ID: 9155692 [TBL] [Abstract][Full Text] [Related]
4. Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Goumenos DS; Brown CB; Shortland J; el Nahas AM Nephrol Dial Transplant; 1994; 9(10):1418-25. PubMed ID: 7816254 [TBL] [Abstract][Full Text] [Related]
5. Interstitial alpha-smooth muscle actin: a prognostic marker in membranous nephropathy. Badid C; Desmoulière A; McGregor B; Costa AM; Fouque D; Hadj Aïssa A; Laville M Clin Nephrol; 1999 Oct; 52(4):210-7. PubMed ID: 10543323 [TBL] [Abstract][Full Text] [Related]
6. Myofibroblast phenotypes expression in experimental renal scarring. Muchaneta-Kubara EC; el Nahas AM Nephrol Dial Transplant; 1997 May; 12(5):904-15. PubMed ID: 9175042 [TBL] [Abstract][Full Text] [Related]
7. The expression of cytoskeletal proteins (alpha-SMA, vimentin, desmin) in kidney tissue: a comparison of fetal, normal kidneys, and glomerulonephritis. Gonlusen G; Ergin M; Paydaş S; Tunali N Int Urol Nephrol; 2001; 33(2):299-305. PubMed ID: 12092643 [TBL] [Abstract][Full Text] [Related]
8. Correlations of tissue macrophages and cytoskeletal protein expression with renal fibrosis in patients with diabetes mellitus. Yonemoto S; Machiguchi T; Nomura K; Minakata T; Nanno M; Yoshida H Clin Exp Nephrol; 2006 Sep; 10(3):186-92. PubMed ID: 17009076 [TBL] [Abstract][Full Text] [Related]
9. A quantitative study of the interstitial expression of alpha-smooth muscle actin (alpha-SMA) in idiopathic membranous glomerulonephritis and minimal change disease in adults. Danilewicz M; Wagrowska-Danilewicz M; Antoszczyk L Pol J Pathol; 2000; 51(1):37-43. PubMed ID: 10833902 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Mezzano SA; Droguett MA; Burgos ME; Ardiles LG; Aros CA; Caorsi I; Egido J Kidney Int; 2000 Jan; 57(1):147-58. PubMed ID: 10620196 [TBL] [Abstract][Full Text] [Related]
11. The role of myofibroblasts and interstitial fibrosis in the progression of membranous nephropathy. Rocha KB; Soares VA; Viero RM Ren Fail; 2004 Jul; 26(4):445-51. PubMed ID: 15462114 [TBL] [Abstract][Full Text] [Related]
12. Cytoskeletal protein expression and regenerative markers in schistosomal nephropathy. El-Koraie AF; Baddour NM; Adam AG; El-Kashef EH; El Nahas AM Nephrol Dial Transplant; 2002 May; 17(5):803-12. PubMed ID: 11981067 [TBL] [Abstract][Full Text] [Related]
13. Myofibroblasts and the progression of crescentic glomerulonephritis. Goumenos D; Tsomi K; Iatrou C; Oldroyd S; Sungur A; Papaioannides D; Moustakas G; Ziroyannis P; Mountokalakis T; El Nahas AM Nephrol Dial Transplant; 1998 Jul; 13(7):1652-61. PubMed ID: 9681707 [TBL] [Abstract][Full Text] [Related]
14. Myofibroblasts and the progression of experimental glomerulonephritis. Zhang G; Moorhead PJ; el Nahas AM Exp Nephrol; 1995; 3(5):308-18. PubMed ID: 7583053 [TBL] [Abstract][Full Text] [Related]
15. Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy. Sanai T; Sobka T; Johnson T; el-Essawy M; Muchaneta-Kubara EC; Ben Gharbia O; el Oldroyd S; Nahas AM Diabetologia; 2000 Jan; 43(1):91-100. PubMed ID: 10663221 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of tubular epithelial cells and vascular endothelial cells in glomerulonephritis. Bob F; Gluhovschi G; Herman D; Petrica L; Bozdog G; Gluhovschi C; Velciov S; Gadalean F; Timar R; Potencz E; Dema A; Schiller A Ren Fail; 2014 Sep; 36(8):1208-14. PubMed ID: 24946133 [TBL] [Abstract][Full Text] [Related]
17. Renal pathology in idiopathic membranous nephropathy: a new perspective. Troyanov S; Roasio L; Pandes M; Herzenberg AM; Cattran DC Kidney Int; 2006 May; 69(9):1641-8. PubMed ID: 16572119 [TBL] [Abstract][Full Text] [Related]
18. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis. Dumoulin A; Hill GS; Montseny JJ; Meyrier A Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220 [TBL] [Abstract][Full Text] [Related]
19. The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. Ranieri E; Gesualdo L; Grandaliano G; Maiorano E; Schena FP J Nephrol; 2001; 14(4):253-62. PubMed ID: 11506247 [TBL] [Abstract][Full Text] [Related]
20. Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction. Badid C; Desmouliere A; Babici D; Hadj-Aissa A; McGregor B; Lefrancois N; Touraine JL; Laville M Nephrol Dial Transplant; 2002 Nov; 17(11):1993-8. PubMed ID: 12401859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]